市场调查报告书
商品编码
1541827
2024-2032 年按应用(化学分析、药物发现、药物验证等)和地区分類的化学资讯学市场报告Chemoinformatics Market Report by Application (Chemical Analysis, Drug Discovery, Drug Validation, and Others), and Region 2024-2032 |
IMARC Group年全球化学资讯学市场规模达63亿美元。
化学资讯学是资讯科技(IT)的一个新领域,专注于化学资料的收集、储存、分析和操作。化学资料包括小分子分子式、结构、性质、光谱以及生物和工业活动。化学资讯学有助于定义檔案资料协议并表示三维 (3D) 分子结构,从而进一步实现对具有特定特征的化合物的搜寻和比较。因此,它被广泛应用于製药行业,以发现和开发新颖的生物技术製程和产品。
目前,冠状病毒病(COVID-19)的爆发是积极影响化学资讯学在抗病毒研究或发现该疾病疗法中的应用的主要因素之一。除此之外,慢性病病例的激增以及随之而来的新药的需求也影响着市场的成长。研发 (R&D) 计画不断增加的投资也促进了对化学资讯学的需求,以验证潜在的候选药物以及有效管理分子和原子反应过程中产生的资料。此外,对个人化医疗的认识不断增强正在推动市场成长。由于合成新药时产生大量资料,领先的市场参与者正在整合化学资讯学中先进的资讯储存和检索技术。这有助于研究人员有效储存有关物理特性、3D 分子和晶体结构、光谱特征、化学反应途径、分子官能基和对接位点以及其他参数的资讯。预计这些创新将推动市场成长。
The global chemoinformatics market size reached US$ 6.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 12.7 Billion by 2032, exhibiting a growth rate (CAGR) of 7.9% during 2024-2032.
Chemoinformatics is a new field of information technology (IT) that focuses on the collection, storage, analysis, and manipulation of chemical data. The chemical data includes small molecule formulas, structures, properties, spectra, and biological and industrial activities. Chemoinformatics helps define archival data protocols and represent three-dimensional (3D) molecular structures, which further enables searching and comparing of compounds with specific features. As a result, it is widely used in the pharmaceutical industry to discover and develop novel biotechnological processes and products.
At present, the outbreak of coronavirus disease (COVID-19) represents one of the major factors positively influencing the utilization of chemoinformatics in anti-viral research or discovery of therapeutics against the disease. Apart from this, the surging cases of chronic diseases and the consequent need for novel drugs are also influencing the market growth. The increasing investments in research and development (R&D) projects are also catalyzing the demand for chemoinformatics to validate potential drug candidates and the effective management of data generated during molecular and atomic reactions. Moreover, the increasing awareness about personalized medicine is driving the market growth. Due to the massive amount of data generated while synthesizing new drugs, the leading market players are integrating advanced information storage and retrieval technologies in chemoinformatics. This helps researchers in efficiently storing information about the physical properties, 3D molecular and crystal structures, spectroscopic signatures, chemical reaction pathways, molecular functional groups and docking sites, and other parameters. These innovations are anticipated to propel the market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global chemoinformatics market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on application.
Chemical Analysis
Drug Discovery
Drug Validation
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Bio-Rad Laboratories Inc., BioSolveIT GmbH, BIOVIA (Dassault Systemes), ChemAxon, Inc., Eurofins CEREP SA (Eurofins Panlabs Inc.), Jubilant Biosys Inc., Molecular Discovery Ltd., OpenEye Scientific Software Inc. and Schrodinger Inc.